VEGF and GLUT1 are highly heritable, inversely correlated and affected by dietary fat intake: Consequences for cognitive function in humans

Rita Schüler, Nicole Seebeck, Martin A Osterhoff, Veronica Witte, Agnes Flöel, Andreas Busjahn, Alexander Jais, Jens C Brüning, Turid Frahnow, Stefan Kabisch, Olga Pivovarova, Silke Hornemann, Michael Kruse, Andreas F H Pfeiffer, Rita Schüler, Nicole Seebeck, Martin A Osterhoff, Veronica Witte, Agnes Flöel, Andreas Busjahn, Alexander Jais, Jens C Brüning, Turid Frahnow, Stefan Kabisch, Olga Pivovarova, Silke Hornemann, Michael Kruse, Andreas F H Pfeiffer

Abstract

Objective: Reduction of brain glucose transporter GLUT1 results in severe neurological dysfunction. VEGF is required to restore and maintain brain glucose uptake across the blood brain barrier via GLUT1, which was shown to be acutely diminished in response to a high fat diet (HFD) in mice. The genetic and HFD-related regulation and association of VEGF and GLUT1 (SLC2A1) in humans was investigated in the NUtriGenomic Analysis in Twins (NUGAT) study.

Methods: 92 healthy and non-obese twins were standardized to a high-carbohydrate low-fat diet for 6 weeks before switched to a 6-week HFD under isocaloric conditions. Three clinical investigation days were conducted: after 6 weeks of low-fat diet and after 1 and 6 weeks of HFD. Serum VEGF and other cytokine levels were measured using ELISA. Gene expression in subcutaneous adipose tissue was assessed by quantitative Real-Time PCR. Genotyping was performed using microarray. The Auditory Verbal Learning Task was conducted to measure cognitive performance.

Results: In this human study, we showed that the environmental regulation of SLC2A1 expression and serum VEGF by HFD was inversely correlated and both factors showed strong heritability (>90%). In response to the HFD containing 45% fat, serum VEGF levels increased (P = 0.002) while SLC2A1 mRNA expression in adipose tissue decreased (P = 0.001). Higher BMI was additionally associated with lower SLC2A1 expression. AA-genotypes of the rs9472159 polymorphism, which explained ∼39% of the variation in circulating VEGF concentrations, showed significantly reduced serum VEGF levels (P = 6.4 × 10-11) but higher SLC2A1 expression (P = 0.009) in adipose tissue compared to CC/CA-genotypes after 6 weeks of HFD. Memory performance in AA-genotypes declined in response to the HFD compared to CC- and CA-genotypes.

Conclusions: The results provide evidence to suggest the translatability of the dietary regulation of VEGF and GLUT1 from mouse models to humans. Our data demonstrate that HFD induces a genetically determined and correlated decrease of GLUT1 and increase of VEGF which may affect memory performance.

Clinical trial registration number: NCT01631123.

Keywords: Cognition; GLUT1; High fat diet; VEGF.

Copyright © 2018 The Authors. Published by Elsevier GmbH.. All rights reserved.

Figures

Figure 1
Figure 1
VEGF levels are highly correlated in monozygous twins. Strong intrapair correlation of VEGF serum concentrations in (A) monozygous twins and no correlation in (B) dizygous twins. **p < 0.01.
Figure 2
Figure 2
VEGF levels increase in response to the 6-week HFD. VEGF serum concentrations at LF6, HF1 and HF6 (mean ± SEM; *p < 0.05, **p < 0.01). LF6, investigation day after 6 weeks of the low fat diet; HF1, investigation day after 1 week of the high fat diet; HF6, investigation day after 6 weeks of the high fat diet.
Figure 3
Figure 3
Reduced gene expression of VEGFA, KDR, and SLC2A1 in subcutaneous adipose tissue in response to HFD. Relative mRNA expression assessed by quantitative Real-Time PCR of (A)VEGFA, (B)KDR and (C)SLC2A1. Values are shown as mean ± SEM. *p < 0.05, ***p < 0.001. To compare the main effects a Repeated Measures ANOVA and Bonferroni adjusted posthoc test was used. LF6, investigation day after 6 weeks of the low fat diet; HF1, investigation day after 1 week of the high fat diet; HF6, investigation day after 6 weeks of the high fat diet.
Figure 4
Figure 4
SLC2A1 gene expression in AT differed between BMI categories.SLC2A1 gene expression in AT at LF6, HF1, and HF6 after stratification for BMI class (**p < 0.01). LF6, investigation day after 6 weeks of the low fat diet; HF1, investigation day after 1 week of the HFD; HF6, investigation day after 6 weeks of the HFD; AT, adipose tissue.
Figure 5
Figure 5
VEGF serum levels and SLC2A1 gene expression levels differed between rs9472159 genotypes. (A) VEGF serum concentrations at LF6, HF1, and HF6 after stratification for rs9472159 genotype and (B) change of VEGF serum concentrations (HF6-LF6) stratified for rs9472159 genotype. (C)SLC2A1 gene expression in AT after stratification rs9472159 genotype. *p < 0.05, **p < 0.01; LF6, investigation day after 6 weeks of the low fat diet; HF1, investigation day after 1 week of the HFD; HF6, investigation day after 6 weeks of the HFD.
Figure 6
Figure 6
Consolidation memory scores according to the Auditory Verbal Learning Task (A) before and after 6 weeks of HFD and (B) before and after HFD stratified by rs9472159 genotype. Consolidation memory score was defined as the number of correct words recalled after the fifth trial subtracted from the number of correct words recalled after 30 min delay, multiplied by −1 to create positive relations. Data are shown as mean ± SEM, *p < 0.05, **p < 0.01. LF6, investigation day after 6 weeks of the low fat diet; HF6, investigation day after 6 weeks of the HFD.

References

    1. Vogt M.C., Bruning J.C. CNS insulin signaling in the control of energy homeostasis and glucose metabolism - from embryo to old age. Trends in Endocrinology and Metabolism. 2013;24:76–84.
    1. Williamson R., McNeilly A., Sutherland C. Insulin resistance in the brain: an old-age or new-age problem? Biochemical Pharmacology. 2012;84:737–745.
    1. Thaler J.P., Yi C.X., Schur E.A., Guyenet S.J., Hwang B.H., Dietrich M.O. Obesity is associated with hypothalamic injury in rodents and humans. Journal of Clinical Investigation. 2012;122:153–162.
    1. Benoit S.C., Kemp C.J., Elias C.F., Abplanalp W., Herman J.P., Migrenne S. Palmitic acid mediates hypothalamic insulin resistance by altering PKC-theta subcellular localization in rodents. Journal of Clinical Investigation. 2009;119:2577–2589.
    1. Wang D., Pascual J.M., Yang H., Engelstad K., Mao X., Cheng J. A mouse model for Glut-1 haploinsufficiency. Human Molecular Genetics. 2006;15:1169–1179.
    1. Winkler E.A., Nishida Y., Sagare A.P., Rege S.V., Bell R.D., Perlmutter D. GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration. Nature Neuroscience. 2015;18:521–530.
    1. Jais A., Solas M., Backes H., Chaurasia B., Kleinridders A., Theurich S. Myeloid-cell-derived VEGF maintains brain glucose uptake and limits cognitive impairment in obesity. Cell. 2016;166:1338–1340.
    1. Choi S.H., Ruggiero D., Sorice R., Song C., Nutile T., Vernon Smith A. Six novel loci associated with circulating VEGF levels identified by a meta-analysis of genome-wide association studies. PLoS Genetics. 2016;12:e1005874.
    1. Debette S., Visvikis-Siest S., Chen M.H., Ndiaye N.C., Song C., Destefano A. Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels. Circulation Research. 2011;109:554–563.
    1. Witte A.V., Fobker M., Gellner R., Knecht S., Floel A. Caloric restriction improves memory in elderly humans. Proceedings of the National Academy of Sciences of the United States of America. 2009;106:1255–1260.
    1. Witte A.V., Kerti L., Margulies D.S., Floel A. Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults. Journal of Neuroscience. 2014;34:7862–7870.
    1. Schuler R., Osterhoff M.A., Frahnow T., Seltmann A.C., Busjahn A., Kabisch S. High-saturated-fat diet increases circulating angiotensin-converting enzyme, which is enhanced by the rs4343 polymorphism defining persons at risk of nutrient-dependent increases of blood pressure. Journal of the American Heart Association. 2017;6
    1. Helmstaedter C., Kurthen M. Memory and epilepsy: characteristics, course, and influence of drugs and surgery. Current Opinion in Neurology. 2001;14:211–216.
    1. Lezak M.D. 4th ed. Oxford University Press; New York: 2004. Neuropsychological assessment.
    1. Stathopoulou M.G., Bonnefond A., Ndiaye N.C., Azimi-Nezhad M., El Shamieh S., Saleh A. A common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-C. Journal of Lipid Research. 2013;54:535–541.
    1. Kalmijn S., Launer L.J., Ott A., Witteman J.C., Hofman A., Breteler M.M. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Annals of Neurology. 1997;42:776–782.
    1. Laitinen M.H., Ngandu T., Rovio S., Helkala E.L., Uusitalo U., Viitanen M. Fat intake at midlife and risk of dementia and Alzheimer's disease: a population-based study. Dementia and Geriatric Cognitive Disorders. 2006;22:99–107.
    1. Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., Bennett D.A., Aggarwal N. Dietary fats and the risk of incident Alzheimer disease. Archives of Neurology. 2003;60:194–200.
    1. Morris M.C., Tangney C.C. Dietary fat composition and dementia risk. Neurobiology of Aging. 2014;35(Suppl 2):S59–S64.
    1. Engelhardt S., Patkar S., Ogunshola O.O. Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia. British Journal of Pharmacology. 2014;171:1210–1230.
    1. Olson A.L., Pessin J.E. Structure, function, and regulation of the mammalian facilitative glucose transporter gene family. Annual Review of Nutrition. 1996;16:235–256.
    1. Pardridge W.M., Boado R.J., Farrell C.R. Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. Journal of Biological Chemistry. 1990;265:18035–18040.
    1. Mani N., Khaibullina A., Krum J.M., Rosenstein J.M. Activation of receptor-mediated angiogenesis and signaling pathways after VEGF administration in fetal rat CNS explants. Journal of Cerebral Blood Flow and Metabolism. 2003;23:1420–1429.
    1. Sone H., Deo B.K., Kumagai A.K. Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells. Investigative Ophthalmology and Visual Science. 2000;41:1876–1884.
    1. Pekala P., Marlow M., Heuvelman D., Connolly D. Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. Journal of Biological Chemistry. 1990;265:18051–18054.
    1. Berrahmoune H., Herbeth B., Lamont J.V., Masson C., Fitzgerald P.S., Visvikis-Siest S. Heritability for plasma VEGF concentration in the Stanislas family study. Annals of Human Genetics. 2007;71:54–63.
    1. Fehm H.L., Kern W., Peters A. The selfish brain: competition for energy resources. Progress in Brain Research. 2006;153:129–140.
    1. Schuler R., Osterhoff M.A., Frahnow T., Mohlig M., Spranger J., Stefanovski D. Dietary fat intake modulates effects of a frequent ACE gene variant on glucose tolerance with association to type 2 diabetes. Scientific Reports. 2017;7:9234.
    1. Dantz D., Bewersdorf J., Fruehwald-Schultes B., Kern W., Jelkmann W., Born J. Vascular endothelial growth factor: a novel endocrine defensive response to hypoglycemia. Journal of Clinical Endocrinology and Metabolism. 2002;87:835–840.
    1. Leung Y.Y., Toledo J.B., Nefedov A., Polikar R., Raghavan N., Xie S.X. Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study. Alzheimer's & Dementia: diagnosis. Assessment & Disease Monitoring. 2015;1:339–348.
    1. Brons C., Jensen C.B., Storgaard H., Hiscock N.J., White A., Appel J.S. Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men. The Journal of Physiology. 2009;587:2387–2397.

Source: PubMed

3
購読する